Last mentioned: Mar 17, 2026
Expected Closing
Final day for institutional and retail investors to bid for shares.
Day 2 Subscription
Market reports muted response with 0% GMP and steady bidding.
IPO Opening
Subscription opens for the Rs 400 crore public issue.
GSP Crop Science has launched its Rs 400 crore initial public offering with a price band of Rs 304-320, primarily targeting debt reduction. Despite the company's established position in the agrochemical sector, early subscription data and a stagnant grey market premium suggest a cautious reception from investors.
This page surfaces every story mentioning GSP Crop Science across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where GSP Crop Science was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |